The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Valproate–Induced Hepatic Injury: Analyses of 23 Fatal Cases
Open accessAbstract
Analyses of 23 fatal instances of hepatic injury in patients taking valproic acid reveals that all but three were less than 20 years old, and all but four had been taking the drugs for more than 1 month. Convulsions, facial edema, lassitude, and vomiting were prominent clinical features. Hypoglycemia was recorded in six patients. Rash and eosinophilia were not seen. Values for transaminases were modestly elevated in most patients. Most levels of SGOT were below 500 IU, and SGPT levels were below 200 IU. Livers showed microvesicular steatosis in most patients, usually accompanies by necrosis. Four patients had cirrhosis. Overt valproic acid–induced hepatic injury appears to be rare and hence, by definition, idiosyncratic. That it may be an idiosyncratic exaggeration of a much more frequent phenomenon is suggested by the higher incidence of seemingly trivial injury. The idiosyncrasy appears to be metabolic rather than immunologic, and the available information leads to the plausible hypothesis that a metabolite is responsible for the microvesicular steatosis seen in most fatal cases. The steatosis resembles that of Reye's syndrome and Jamaican vomiting sickness, and there is reason to believe that the metabolite responsible for the steatosis resembles the agent responsible for Jamaican vomiting sickness. A different metabolite is presumably responsible for the necrosis seen in many of the cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of Clinical Neurology
Boyd, J. F. (1979) · Journal of Clinical Pathology · doi:10.1136/jcp.32.3.312 · Cited by 891
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Leung, D. M., Kurt-Jones, E., Newburger, J., Cotran, R., Burns, J., & Pober, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91910-7 · Cited by 381
Reye-like syndrome associated with valproic acid therapy
Gerber, N., Dickinson, R. G., Harland, R. C., Lynn, R. K., Houghton, D., Antonias, J. I., & Schimschock, J. C. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80110-9 · Cited by 224
Jamaican Vomiting Sickness: Biochemical Investigation of Two Cases
Tanaka, K., Kean, E. A., & Johnson, B. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608262950901 · Cited by 209
Koch-Weser, J., & Browne, T. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198003203021204 · Cited by 167
Acute Hepatic Failure Associated with the Use of Sodium Valproate: Report of Two Fatal Cases
Suchy, F. J., Balistreri, W. F., Buchino, J. J., Sondheimer, J. M., Bates, S. R., Kearns, G. L., Stull, J. D., & Bove, K. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197904263001706 · Cited by 163
SECONDARY HYPERAMMONÆMIA: A POSSIBLE MECHANISM FOR VALPROATE ENCEPHALOPATHY
Coulter, D. L., & Allen, R. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91773-0 · Cited by 143
A Direct Hepatotoxic Effect of Valproic Acid
Sussman, N. M. (1979) · JAMA · doi:10.1001/jama.1979.03300110045025 · Cited by 104
Valproic Acid Therapy in Childhood Epilepsy
Coulter, D. L. (1980) · JAMA · doi:10.1001/jama.1980.03310080019016 · Cited by 98
ACUTE LIVER DISEASE ASSOCIATED WITH SODIUM VALPROATE
Ware, S. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92543-x · Cited by 67
Phenobarbital-valproic acid interaction
Patel, I. H., Levy, R. H., & Cutler, R. E. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.72 · Cited by 64
Fatal reye‐like syndrome associated with valproic acid
Young, R. S. K., Bergman, I., Gang, D. L., & Richardson, E. P. (1980) · Annals of Neurology · doi:10.1002/ana.410070423 · Cited by 61
SODIUM VALPROATE AND ORNITHINE CARBAMYL TRANSFERASE DEFICIENCY
Tripp, J. H. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92338-2 · Cited by 51
Thurston, J. H., Hauhart, R. E., Schulz, D. W., Naccarato, E. F., Dodson, W. E., & Carroll, J. E. (1981) · Neurology · doi:10.1212/wnl.31.9.1063 · Cited by 37
Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid
Schmid, R. (1977) · Clinica Chimica Acta · doi:10.1016/0009-8981(77)90385-0 · Cited by 27
Fatal hepatotoxicity in child on phenobarbitone and sodium valproate.
Jacobi, G., Thorbeck, R., Ritz, A., Janssen, W., & Schmidts, H.-L. (1980) · PubMed · Cited by 25
Cited by
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00012-6 · Cited by 665
Begriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 555
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
Silva, M. F. B., Aires, C. C. P., Luis, P. B. M., Ruiter, J. P. N., IJlst, L., Duran, M., Wanders, R. J. A., & Tavares de Almeida, I. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0841-x · Cited by 382
Idiosyncratic Adverse Reactions to Antiepileptic Drugs
Zaccara, G., Franciotta, D., & Perucca, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01041.x · Cited by 364
Adverse drug reactions induced by valproic acid
Nanau, R. M., & Neuman, M. G. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.06.012 · Cited by 321
Metadata
- Authors
- Zimmerman, H. J., & Ishak, K. G.
- Venue
- Hepatology
- Published
- 1982-09
- Volume
- 2
- Issue
- 5
- Pages
- 591S-597S
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2043419877
- Cited by
- 393
- References
- 17
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.